Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health
Reference16 articles.
1. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial;Heijerman;Lancet,2019
2. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del Allele;Middleton;N Engl J Med,2019
3. The efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease;O'Shea;Eur Respir J,2020
4. Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease;Burgel;Am J Respir Crit Care Med,2021
5. CFTR-function and ventilation inhomogeneity in individuals with cystic fibrosis;Bernasconi;J Cyst Fibros,2020